Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants

Dabigatran etexilate (DE), rivaroxaban, and apixaban are nonvitamin K antagonist oral anticoagulants (NOACs) that have been compared in clinical trials with existing anticoagulants (warfarin and enoxaparin) in several indications for the prevention and treatment of thrombotic events. All NOACs prese...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sarah, Lessire, Anne-Sophie, Dincq, Jonathan, Douxfils, Bérangère, Devalet, Jean-Baptiste, Nicolas, Anne, Spinewine, Anne-Sophie, Larock, Jean-Michel, Dogné, Maximilien, Gourdin, François, Mullier
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2014
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4084591/
https://ncbi.nlm.nih.gov/pubmed/25032218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/616405
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars